Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach

Cancer Epidemiology and Prevention

(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369

Two pathogenetic types of endometrial carcinoma

Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,494

Cancer statistics, 1996

Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1996) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.1.5 · Cited by 1,759

The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients

Kurman, R. J., Kaminski, P. F., & Norris, H. J. (1985) · Cancer · doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x · Cited by 1,252

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. E., & Ellenson, L. H. (1997) · PubMed · Cited by 701

Molecular Mechanisms of Estrogen Carcinogenesis

Yager, J. D., & Leihr, J. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001223 · Cited by 654

Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium

Cooke, P. S., Buchanan, D. L., Young, P., Setiawan, T., Brody, J., Korach, K. S., Taylor, J., Lubahn, D. B., & Cunha, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6535 · Cited by 554

Microsatellite instability: marker of a mutator phenotype in cancer.

Loeb, L. A. (1994) · PubMed · Cited by 546

Genetic instability of microsatellites in endometrial carcinoma.

Risinger, J. I., Berchuck, A., Kohler, M. F., Watson, P. A., Lynch, H. T., & Boyd, J. A. (1993) · PubMed · Cited by 517

PTEN/MMAC1 mutations in endometrial cancers.

Risinger, J. I., Hayes, A. K., Berchuck, A., & Barrett, J. C. (1997) · PubMed · Cited by 506

Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40

RANDALL, T., & KURMAN, R. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00297-4 · Cited by 425

Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes.

Hussain, S. P., & Harris, C. C. (1998) · PubMed · Cited by 407

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

Tashiro, H., Isacson, C., Levine, R. L., Kurman, R. J., Cho, K. R., & Hedrick, L. (1997) · Europe PMC (PubMed Central) · Cited by 345

p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis

Sherman, M. E., Bur, M. E., & Kurman, R. J. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90204-x · Cited by 342

Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features

Sherman, M. E., Bitterman, P., Rosenshein, N. B., Delgado, G., & Kurman, R. J. (1992) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199206000-00008 · Cited by 327

Progression of Pancreatic Intraductal Neoplasias to Infiltrating Adenocarcinoma of the Pancreas

Brat, D. J., Lillemoe, K. D., Yeo, C. J., Warfield, P. B., & Hruban, R. H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199802000-00003 · Cited by 309

Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation

Ambros, R. A., Sherman, M. E., Zahn, C. M., Bitterman, P., & Kurman, R. J. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90203-1 · Cited by 305

Case--Control Study of Endogenous Steroid Hormones and Endometrial Cancer

Potischman, N., Hoover, R. N., Brinton, L. A., Siiteri, P., Dorgan, J. F., Swanson, C. A., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1127 · Cited by 297

PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma.

Levine, R. L., Cargile, C. B., Blazes, M. S., van Rees, B. P., Kurman, R. J., & Ellenson, L. H. (1998) · PubMed · Cited by 295

Microsatellite instability in inherited and sporadic neoplasms

Eshleman, J. R., & Markowitz, S. D. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199501000-00013 · Cited by 262

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: Report of seven cases and review of the literature

Kim, Y. B., Holschneider, C. H., Ghosh, K., Nieberg, R. K., & Montz, F. J. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2<320::aid-cncr15>3.0.co;2-2 · Cited by 259

Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.

Maxwell, G. L., Risinger, J. I., Gumbs, C. E., Shaw, H., Bentley, R. C., Barrett, J. C., Berchuck, A., & Futreal, P. A. (1998) · PubMed · Cited by 231

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler, M. F., Berchuck, A., Davidoff, A. M., Humphrey, P., Rk, D., Jd, I., Jt, S., Clarke-Pearson, D., Bast, R. C., & Маркс (1992) · PubMed · Cited by 229

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression

Lax, S. F., Pizer, E. S., Ronnett, B. M., & Kurman, R. J. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)80002-6 · Cited by 227

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

Ferenczy, A., & Gelfand, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90103-8 · Cited by 224

Causes and consequences of microsatellite instability in endometrial carcinoma.

Gurin, C. C., Federici, M. G., Kang, L., & Boyd, J. A. (1999) · PubMed · Cited by 215

Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

Carcangiu, M. L., & Chambers, J. T. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90130-b · Cited by 211

Report of seven cases and review of the literature

Domingue, J. N., & Wilson, C. B. (1977) · Cited by 202

Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.

Peiffer, S. L., Herzog, T. J., Tribune, D. J., Mutch, D. G., Gersell, D. J., & Goodfellow, P. J. (1995) · PubMed · Cited by 179

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

Sasaki, H., Nishii, H., Takahashi, H., Tada, A., Furusato, M., Terashima, Y., Siegal, G. P., Parker, S. L., Kohler, M. F., & Berchuck, A. (1993) · PubMed · Cited by 176

The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the Uterus

Bitterman, P., Chun, B., & Kurman, R. J. (1990) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199004000-00002 · Cited by 162

K-ras activation in premalignant and malignant epithelial lesions of the human uterus.

Enomoto, T., Inoue, M., Perantoni, A. O., Buzard, G. S., Miki, H., Tanizawa, O., & Rice, J. M. (1991) · PubMed · Cited by 156

Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

Sherman, M. E., Sturgeon, S. R., Brinton, L. A., Potischman, N. A., Kurman, R. J., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., & Wilbanks, G. D. (1997) · PubMed · Cited by 152

Serous carcinoma in endometrial polyps.

Silva, E. G., & Jenkins, R. (1990) · PubMed · Cited by 145

Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.

Watanabe, K., Sasano, H., Harada, N., Ozaki, M., Niikura, H., Sato, S., & Yajima, A. (1995) · Europe PMC (PubMed Central) · Cited by 122

A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers.

Mutter, G. L., Chaponot, M. L., & Fletcher, J. A. (1995) · PubMed · Cited by 106

CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors

Bulun, S. E., Economos, K., Miller, D. S., & Simpson, E. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989490 · Cited by 106

Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer.

Mutter, G. L., Boynton, K. A., Faquin, W. C., Ruiz, R., & Jovanovic, A. (1996) · PubMed · Cited by 96

Racial differences in endometrial cancer survival: The black/white cancer survival study

AHILL, H., WILLIAMELEY, J., CHARLAN, L., SGREENBERG, R., JBARRETTII, R., & WCHEN, V. (1996) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00341-9 · Cited by 90

Uterine papillary serous carcinoma evolves via a p53-driven pathway

Moll, U. M., Chalas, E., Auguste, M., Meaney, D., & Chumas, J. C. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90340-8 · Cited by 86

Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

Caduff, R. F., Johnston, C. M., & Frank, T. S. (1995) · Europe PMC (PubMed Central) · Cited by 84

p53 Expression in Neoplasms of the Uterine Corpus

Bur, M. E., Perlman, C., Edelmann, L. J., Fey, E. G., & Rose, P. G. (1992) · American Journal of Clinical Pathology · doi:10.1093/ajcp/98.1.81 · Cited by 80

Endometrial cancer: Stage at diagnosis and associated factors in black and white patients

Barrett, R. J., Harlan, L. C., Wesley, M. N., Hill, H. A., Chen, V. W., Clayton, L. A., Kotz, H. L., Eley, J. W., Robboy, S. J., & Edwards, B. K. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90261-9 · Cited by 62

Correlations between p21 expression and clincopathological finding, p53 gene and protein alteration, and survival in patients with endometrial carcinoma

Ito, K., Sasano, H., Matsunaga, G., Sato, S., Yajima, A., Nasim, S., & Garret, C. T. (1997) · The Journal of Pathology · Cited by 62

Relationship between race and interval to treatment in endometrial cancer

Liu, J., Conaway, M. C., Rodríguez, G., et al. (1995) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(95)80002-6 · Cited by 60

Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias

Kohler, M. F., Nishii, H., Humphrey, P. A., Saski, H., Marks, J. R., Bast, R. C., Clarke‐Pearson, D. L., Boyd, J. A., & Berchuck, A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90644-x · Cited by 53

Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutations

Boyd, J. A., & Risinger, J. I. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040305 · Cited by 53

Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart.

Esteller, M., García, A. V., Martínez-Palones, J. M., Xercavins, J., & Reventós, J. (1997) · PubMed · Cited by 33

Type I and II Endometrial Cancers: Have They Different Risk Factors?

Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer

Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, Le Gallo, M., O'Hara, A. J., Rudd, M. L., Urick, M. E., Hansen, N. F., O'Neil, N. J., Price, J. C., Zhang, S., England, B. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2455 · Cited by 419

Body mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis

Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M., & Renehan, A. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0832 · Cited by 321

Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition

Dossus, L., Allen, N., Kaaks, R., Bakken, K., Lund, E., Tjonneland, A., Olsen, A., Overvad, K., Clavel‐Chapelon, F., Fournier, A., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25050 · Cited by 296